SCHEMBL353653

SCHEMBL353653

Cc1cccc(Cc2c(-c3ccc4c(C(N)=O)cccc4c3Cc3cccc(C)c3)ccc3c(C(N)=O)cccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 3/20 0.46
AURKA O14965 3/20 0.46
ADRA1D P25100 1/20 0.44
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPK8 P45983 1/20 0.43
PARP1 P09874 2/20 0.40
SIRT2 Q8IXJ6 1/20 0.39
NR3C2 P08235 1/20 0.39
CD38 P28907 1/20 0.39
AURKB Q96GD4 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
RAB9A P51151 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
GAA P10253 1/20 0.37
PARP2 Q9UGN5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL352441 0.88 RPS6KB1 (0.46) RPS6KB1AURKAADRA1DKDM4EALDH1A1
SCHEMBL355055 0.83 CD38 (0.39) RPS6KB1AURKAKDM4EALDH1A1PARP1
SCHEMBL353377 0.75 SIRT2 (0.47) RPS6KB1AURKAADRA1DKDM4EALDH1A1
SCHEMBL4977141 0.75 KDM4E (0.49) RPS6KB1AURKAADRA1DKDM4EALDH1A1
SCHEMBL8993103 0.72 KDM4E (0.47) RPS6KB1AURKAADRA1DKDM4EALDH1A1
SCHEMBL634715 0.72 KMT2A (0.46) KDM4EALDH1A1HPGDHSD17B10PARP1
SCHEMBL6135290 0.69 ATM (0.61) AURKAKDM4EALDH1A1HPGDHSD17B10
SCHEMBL241943 0.68 RPS6KB1 (0.41) RPS6KB1AURKAKDM4EALDH1A1PARP1
SCHEMBL6173916 0.68 PARP1 (0.43) MAPK8PARP1CD38
SCHEMBL10274480 0.67 KDM4E (0.61) AURKAKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120015992-A1 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2012-01-19 US disclosed
US-8039668-B2 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015992-A1 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins HAX1, PRDX1, APOL1 RPS6KB1 4384/4885AURKA 3871/4885ADRA1D 2836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.